JNJ Stock Plunges 2.3% as Pharma Sector Sees Broad Weakness

Johnson & Johnson stock closed at $268.82 on the NYSE on September 8, 2026, down 2.33 percent from the previous session.

This decline trailed the broader market, with the S&P 500 falling 0.32 percent to 7,693.60, according to Reuters.

The pharma sector as a whole saw weakness, with the health care ETF XLV down 1.9 percent, as reported by MSN.

The company's stock has traded below its recent peak after reaching an all-time high last week.